Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

M. Colhoun, Helen; Livingstone, Shona; C. Looker, Helen; D. Morris, Andrew; H. Wild, Sarah; S. Lindsay, Robert; Reed, C.; T. Donnan, Peter; Guthrie, Bruce; Leese, Graham; McKnight, John; Pearson, D.; R. Pearson, Ewan; R. Petrie, John; Philip, Sam; Sattar, N; Sullivan, Frank; McKeigue, Paul

doi:10.1007/s00125-012-2668-0

Public

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs

Published in Diabetologia • Sep 3, 2012

Authors:

Helen M. Colhoun

Shona Livingstone

Helen C. Looker

Abstract

AIMS/HYPOTHESIS: Current drug labels for thiazolidinediones (TZDs) warn of increased fractures, predominantly for distal fractures in women. We examined whether exposure to TZDs affects hip fracture in women and men and compared the risk to that found with other drugs used in diabetes. METHODS: Usin...

Subject

Rosiglitazone

Pioglitazone

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!